Assyro AI

Orange Book product · Generic (ANDA)

TAMSULOSIN HYDROCHLORIDE

TAMSULOSIN HYDROCHLORIDE

Generic (ANDA)ANDA 214730TE ABRX ASCENT PHARMS INC
View TAMSULOSIN HYDROCHLORIDE familyOpen on FDA Orange Book

At a glance

May 04, 2022

Approved

Generic (ANDA)

Application

AB

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    May 04, 2022

    4 yr 2 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

TAMSULOSIN HYDROCHLORIDE

Strength

0.4MG

Dosage form

CAPSULE

Route

ORAL

TE code

AB

Application

ANDA 214730

Product number

001

Marketing status

RX

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of TAMSULOSIN HYDROCHLORIDE

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo